XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions
3 Months Ended
Mar. 31, 2024
Related Party Transaction [Line Items]  
Related Party Transactions

13. RELATED PARTY TRANSACTIONS

Transactions with University of Maryland

The Company has contracts with UMD, including contracts to provide certain quantum computing services and facility access, to provide customized quantum computing hardware, and an operating lease. Following the departure of the Company's Chief Scientist, UMD is no longer

considered a related party as of January 1, 2024. Revenue recognized for the three months ended March 31, 2024 and 2023, from contracts entered into while UMD was a related party, was $1.2 million and $1.0 million, respectively.

The Company had the following balances related to contracts entered into while UMD was a related party, as reflected in the condensed consolidated balance sheets (in thousands):

 

 

 

March 31,

 

 

December 31,

 

 

2024

 

 

2023

 

Assets

 

 

 

 

 

 

Operating lease right-of-use asset

 

 

3,373

 

 

 

3,452

 

Liabilities

 

 

 

 

 

 

Current portion of operating lease liabilities

 

 

666

 

 

 

661

 

Unearned revenue

 

 

1,447

 

 

 

2,670

 

Operating lease liabilities, net of current portion

 

 

3,101

 

 

 

3,181

 

Transactions with Duke University

In July 2016, the Company entered into an exclusive license agreement (the “License Agreement”) and an exclusive option agreement (the “Option Agreement”) with Duke whereby the Company, in the normal course of business, has licensed certain intellectual property and, in the case of the amendments to the Option Agreements, has purchased research and development services. The Company considers these agreements to be related party transactions because the Company’s Scientific Advisor and former Chief Technology Officer serves as a professor at Duke. The Company’s Scientific Advisor and former Chief Technology Officer continues to lead the research subject to the License Agreement and Option Agreement with Duke as of March 31, 2024. The Company recognized $0.1 million of research and development expense related to these agreements during the three months ended March 31, 2024 and 2023.

The Company has the following balances related to these agreements, as reflected in the condensed consolidated balance sheets (in thousands):

 

 

 

March 31,

 

 

December 31,

 

 

2024

 

 

2023

 

Assets

 

 

 

 

 

 

Prepaid expenses and other current assets

 

$

520

 

 

$

520

 

Other noncurrent assets

 

 

675

 

 

 

805